OBJECTIVES: The aims of this study were to use symptom intensity measures collected at each session (1) to describe the outcomes of clients who received cognitive therapy (CT) for depression in a clinically representative sample, and (2) to compare the outcomes of clients who completed the agreed number of sessions with those who did not. DESIGN AND METHOD: Clients (N = 58) contracted to attend between 12 and 20 sessions of CT completed the Beck Depression Inventory (BDI) immediately prior to each therapy session. The BDI and other measures were collected at intake and, for those who completed therapy, at a post-therapy assessment. RESULTS: Completers' BDI scores improved significantly from intake to post-treatment and significantly more from intake to their final session than did those of non-completers. However, when non-completers' final session scores were matched with scores of randomly selected completers at the corresponding session, the difference in improvement was not significant. A significantly higher proportion of clients who completed the agreed number of sessions achieved reliable and clinically significant change (71.4%, 25/35), compared with just 13% (3/23) of clients who did not. CONCLUSIONS: (1) CT for depression can be effective in a clinically representative population. (2) Attrition from clinical trials may bias estimates of treatment effectiveness.
OBJECTIVES: The aims of this study were to use symptom intensity measures collected at each session (1) to describe the outcomes of clients who received cognitive therapy (CT) for depression in a clinically representative sample, and (2) to compare the outcomes of clients who completed the agreed number of sessions with those who did not. DESIGN AND METHOD: Clients (N = 58) contracted to attend between 12 and 20 sessions of CT completed the Beck Depression Inventory (BDI) immediately prior to each therapy session. The BDI and other measures were collected at intake and, for those who completed therapy, at a post-therapy assessment. RESULTS: Completers' BDI scores improved significantly from intake to post-treatment and significantly more from intake to their final session than did those of non-completers. However, when non-completers' final session scores were matched with scores of randomly selected completers at the corresponding session, the difference in improvement was not significant. A significantly higher proportion of clients who completed the agreed number of sessions achieved reliable and clinically significant change (71.4%, 25/35), compared with just 13% (3/23) of clients who did not. CONCLUSIONS: (1) CT for depression can be effective in a clinically representative population. (2) Attrition from clinical trials may bias estimates of treatment effectiveness.
Authors: Marna S Barrett; Wee-Jhong Chua; Paul Crits-Christoph; Mary Beth Gibbons; D Casiano; Don Thompson Journal: Psychotherapy (Chic) Date: 2008-06-01
Authors: D A van Dijk; M L Deen; Th M van den Boogaard; H G Ruhé; J Spijker; F P M L Peeters Journal: Eur Arch Psychiatry Clin Neurosci Date: 2022-10-17 Impact factor: 5.760
Authors: Clara Strauss; Amy Arbon; Michael Barkham; Sarah Byford; Rebecca Crane; Richard de Visser; Margaret Heslin; Anna-Marie Jones; Fergal Jones; Laura Lea; Glenys Parry; Claire Rosten; Kate Cavanagh Journal: Trials Date: 2020-05-04 Impact factor: 2.279
Authors: Nick Firth; Michael Barkham; Jaime Delgadillo; Kai Allery; Jonathan Woodward; Alicia O'Cathain Journal: Adm Policy Ment Health Date: 2021-11-27
Authors: Leslie Shanks; Cono Ariti; M Ruby Siddiqui; Giovanni Pintaldi; Sarah Venis; Kaz de Jong; Marise Denault Journal: Confl Health Date: 2013-09-16 Impact factor: 2.723